OCULAR THERAPEUTIX, INC - OCUL

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$2.063B
QoQ value delta ($000)
+$254.5M (+14.07%)
Implied price effect (QoQ)
+15.01%
Shares
Total shares
210,142,152
QoQ shares delta
-1,721,299 (-0.81%)
Total shares held by funds (by quarter)

Market chart (OCUL)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 265 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
FMR LLC 322,528 32,844,043 0.01%
Deep Track Capital, LP 193,319 19,686,282 2.81%
BlackRock, Inc. 190,277 19,376,555 0.0%
Avoro Capital Advisors LLC 123,142 12,540,000 1.11%
SUMMER ROAD LLC 119,885 12,208,296 74.46%
Venrock Adviser, LLC 101,606 10,346,926 3.08%
VANGUARD CAPITAL MANAGEMENT LLC 86,736 8,832,595 0.0%
PRICE T ROWE ASSOCIATES INC /MD/ 74,864 7,623,533 0.01%
Logos Global Management LP 52,046 5,300,000 2.24%
STATE STREET CORP 51,390 5,233,282 0.0%
GEODE CAPITAL MANAGEMENT, LLC 49,315 5,021,092 0.0%
Point72 Asset Management, L.P. 32,329 3,292,193 0.04%
BALYASNY ASSET MANAGEMENT L.P. 31,874 3,245,907 0.04%
DIMENSIONAL FUND ADVISORS LP 27,334 2,783,367 0.0%
DELTEC ASSET MANAGEMENT LLC 24,316 2,476,197 3.59%
Octagon Capital Advisors LP 20,376 2,075,000 1.83%
VANGUARD PORTFOLIO MANAGEMENT LLC 19,376 1,973,130 0.0%
NORTHERN TRUST CORP 17,670 1,799,426 0.0%
GOLDMAN SACHS GROUP INC 17,300 1,761,754 0.0%
Nuveen, LLC 16,667 1,697,274 0.0%
Woodline Partners LP 16,375 1,667,609 0.05%
TCG Crossover Management, LLC 16,180 1,647,752 0.39%
UBS Group AG 15,230 1,551,001 0.0%
ADAGE CAPITAL PARTNERS GP, L.L.C. 15,221 1,550,000 0.02%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 15,058 1,533,438 0.0%